modelFood
Extends from Pharmacolibrary.Drugs.ATC.V.V01AA08.
Information
| name: | Food | |
| ATC code: | V01AA08 | route: | orally |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Substances classified under ATC code V01AA08 refer to 'Test meals for functional investigation', commonly known as food used in diagnostic settings to assess gastrointestinal function. These are not drugs in the classical sense but standardized meals or food compositions employed to study digestion, absorption, or metabolism and are not intended as therapeutics. There is no approved pharmaceutical use for these products beyond clinical or experimental diagnostics.
Pharmacokinetics
Pharmacokinetic models for standard 'food' test meals do not exist, as foods are not pharmacological agents and lack defined PK parameters such as absorption, distribution, metabolism, and elimination in the conventional sense. No peer-reviewed pharmacokinetic model for test meals or 'food' with this ATC code exists.
References
Chen, G, et al., & Nomikos, G (2018). Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. Clinical pharmacokinetics 57(6) 673–686. DOI:10.1007/s40262-017-0612-7 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29189941
Greenberg, RG, et al., & Walter, EB (2022). Population Pharmacokinetics of Moxifloxacin in Children. Paediatric drugs 24(2) 163–173. DOI:10.1007/s40272-022-00493-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35284983
Fernandez-Teruel, C, et al., & Zhou, D (2024). Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63(8) 1191–1204. DOI:10.1007/s40262-024-01407-x PUBMED:https://pubmed.ncbi.nlm.nih.gov/39127854
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.9 | Volume of distribution (L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 0.8 | bioavailiability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 20 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1000 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | elimination half-life |
Revisions
- 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)